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unique and very specialized periodontal tissues: the PDL, the root cementum, and the alveolar bone. 1, 3 Periodontal regeneration is an extremely complex process that requires new bone, cementum, and connective tissue formation. 1 PDL cells (PDLCs) present multilineage differentiation capacity, playing a key role in periodontal regeneration. 4, 5 The multipotent mesenchymal stem cells contained in the PDL tissue are essential for the ongoing remodeling of periodontium, as well as for the healing response to injury. 6 A recent study suggests that approximately 30% of a population of PDLCs possess replicative and multipotency potential, and thus could be steered to differentiate into cells with osteoblast-and cementoblast-like properties. 7 The outcome of such regenerative potential includes the capacity to form mineralized nodules, expression of the bone-and cementum-associated markers, and response to bone inductive factors. 4, 5, 7, 8 Agents stimulating proliferation and differentiation of PDLCs into osteoblast-like cells are of interest for periodontal tissue regeneration. 9 Such agents could lead to enhanced tissue regeneration by guiding the PDLC population to produce lost bone tissue. 7 Regarding the differentiation of PDLCs into osteoblast-like cells, the use of strontium (Sr) as a stimulating agent is a feasible possibility. 10, 11 Sr was first advocated as an adjunct for the treatment of osteoporosis and has been suggested to perform a dual action in bone tissue, both stimulating bone formation and suppressing bone resorption, simultaneously. 12 Studies on the effect of systemic treatment with Sr have suggested that this element might be an effective route to enhance the regeneration of bone defects, and the osseointegration of titanium implants. 13, 14 Based on the osteogenic activity induced by Sr, the use of this element in periodontal regeneration would be reasonable. However, only few studies have addressed the direct interaction between Sr and the behavior of PDLCs. 15, 16 One of these studies suggests non-toxic effects of Sr, in the form of strontium ranelate, when used in concentrations as high as 20 mg/mL, 15 while the other ratifies its possibility to promote PDLCs proliferation, at a concentration of 3 mmol/L, or approximately 260 mg/L (in the form of SrCl 2 ). 16 The effects of varying concentrations of Sr on the osteogenic behavior of PDLCs, and the proper genetic pathways, which are activated when this stimulating agent is used, have not been investigated.
Thus, the objective of the present study was to investigate the effect of a high concentration of Sr on PDLCs growth and osteogenic behavior. 
| MATERIAL AND ME THODS

| Primary cell culture
| Strontium concentration
Cells were cultured without (Ctrl) or with one of four increasing Sr concentrations, defining the group they were allocated to: Sr1, the physiological level of Sr in the human serum (11. higher concentration than that previously tested in the literature).
Strontium was added as strontium chloride hexahydrate (SrCl 2 •6H 2 O, Sigma-Aldrich).
| Cell morphology -spreading area
Cells were seeded at a density of 15 × 10 3 cells/cm 2 in 24-well plates (containing a round regular plastic coverslip -Sigma-Aldrich -Ø 12 mm -in the bottom of the well), divided according to the groups (Ctrl and Sr1-4). The cells were fixed with 10% formalin solution (approximately 4% formaldehyde) after 2, 4, 6, and 24 hours of culture.
Quantification of cell spreading area was carried out using immunofluorescence. For cell counting, the nucleus was stained using DAPI nucleic acid stain (D9542, Sigma-Aldrich). The F-action in the cy- 
| Cell proliferation
Cells were seeded at a density of 15 × 10 3 cells/cm 2 in 24-well plates, divided according to the groups, in the presence or absence of Sr. The cells were harvested after 1, 3, and 7 days of culture.
For each period, the cells were trypsinized with 0.25% TrypLE™
Express reagent, no-phenol red (Gibco, Paisley, UK), and thereafter counted using NucleoCounter™ (ChemoMetec, Allerod, Denmark).
The cell count was made by adding 100 μL of culture sample to 100 μL of lysis buffer in a tube and was shaken vigorously. Later, 100 μL of staining was added to the mixture and, again, shaken
vigorously. Approximately 100 μL of sample was loaded into the NucleoCassete™. This procedure provided a total cell count (cells/ mL), based on the number of stained cell nuclei, in about 30 seconds.
| Alkaline phosphatase activity assay
The ability of alkaline phosphatase (ALP) to hydrolyze the colorless and used to calculate cell-specific ALP activity, which was expressed as mmol/L pNP/minute/cell. The pNPP substrate and the 2 mol/L NaOH stop solution were added at the same time as to the samples, providing the standard curve. Data were calculated for Sr and Ctrl groups after 7 and 14 days of culture. by the geometric mean of threshold cycles from ribosomal protein L13a, glucuronidase, beta and beta-2-microglobulin.
| Gene expression -RNA isolation and real-time RT-PCR analysis
| Mineralization
Differentiated osteoblasts can be induced to produce vast extracellular calcium deposits in vitro (ie, mineralization) and these deposits can be stained in bright orange-red using Alizarin Red staining. 18 To assess calcium deposition by Alizarin Red staining, 
| Statistical analysis
All experiments were performed in triplicate (ie, in all experiments, three samples per group/period were tested). The data were described as means and standard deviations. GraphPad Prism 6.0 for Windows (GraphPad Software Inc., La Jolla, USA) was used for the statistical evaluation. Normality of the data was tested and confirmed with the Kolgomorov-Smirnov test, and comparisons (group-and period-wise)
were made using Tukey post hoc test followed a parametric one-way ANOVA. The minimum statistical significance was set at P ≤ 0.05.
| RE SULTS
| Cell morphology -spreading area
Considering the spreading area of the cultured cells, Sr3 and Sr4 lead to larger areas than those associated to Ctrl, Sr1 and Sr2 at 4 hours period. Ctrl, Sr1, and Sr2 groups reached the same areas only after 6 hours of evaluation. Yet, at 24 hours, Sr3 and Sr4 showed larger values than the control group (P ≤ 0.05 and P ≤ 0.01, respectively).
These results are presented in Figure 1 .
| Cell proliferation
As shown in Figure 2 , for all Sr groups as well as the control, cell counts increased significantly according to the assessment period (ie, from 1 to 3, and then from 3 to 7 days of culture, P ≤ 0.001).
Considering the differences among the groups within the same assessment period of evaluation, Sr3 and Sr4 showed significantly larger number of cells compared to lower Sr concentrations and the control group. At 7 days, Sr4 also led to a significantly larger number of cells than Sr3 (P ≤ 0.001).
| ALP activity
For all groups, there was a significant increase in ALP activity from 7 to 14 days (P ≤ 0.001). Sr4 showed significantly lower ALP activity at both 7 and 14 days when compared to Ctrl and other Sr groups (ie, Sr1, Sr2, Sr3, and Ctrl -P ≤ 0.001), as it can be seen in Figure 3 .
| Gene expression
RT-PCR showed that osteogenic gene expression was altered by the addition of Sr to the culture medium, especially considering the highest tested Sr concentration (Sr4). Expression of RUNX2 was transiently lower at 7 and 14 days, when subject to Sr4, compared to the other groups. Overall, the peak of gene expression took place at 7 days. At 1, 3, and 21 days, all groups showed equal results regarding RUNX2 expression, but at 7 days, Sr4 showed lower levels of gene expression than all other groups ( Figure 4 ).
Considering ALP, and as seen in Figure 5 , the gene expression for Sr4 group was significantly lower than that seen for the other groups The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. a-difference from Ctrl, P ≤ 0.05; aa-difference from Ctrl, P ≤ 0.01; aaa-difference from Ctrl, P ≤ 0.001; b-difference from Sr1, P ≤ 0.05; cc-difference from Sr2, P ≤ 0.01; ccc-difference from Sr2, P ≤ 0.001; Tukey post hoc test followed ANOVA F I G U R E 2 PDLCs proliferation (mean ± SD) for the control and the diverse Sr concentrations at the three evaluation periods. The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. aa-difference from Ctrl, P ≤ 0.01; aaa-difference from Ctrl, P ≤ 0.001; b-difference from Sr1, P ≤ 0.05; bb-difference from Sr1, P ≤ 0.01; bbbdifference from Sr1, P ≤ 0.001; c-difference from Sr2, P ≤ 0.05; cc-difference from Sr2, P ≤ 0.01; ccc-difference from Sr2, P ≤ 0.001; ddd-difference from Sr3, P ≤ 0.001; Tukey post hoc test followed ANOVA ( Figure 6 ). OCN expression showed a peak at 7 day for all groups, reaching lower values after that. Sr4 showed significantly larger gene expression compared to all other groups at 7, 14, and 21 days (Figure 7 ).
Sr4 OPG gene expression was up-regulated compared to the other Sr concentrations at 7 days. The other Sr concentrations, as
well as the control group reached similar expression levels at 14 days of evaluation. However, at 21 days, Sr3 and Sr4 showed larger values than the other groups (Sr2, Sr1, and Ctrl). For both Sr3 and Sr4, the difference was with a significance of P ≤ 0.01, compared to Sr2, Sr1, and Ctrl.These results are presented in Figure 8 .
| Mineralization
Mineralization, as assessed by subjective Alizarin Red-positive nodules formed in the PDLC cultures after 14 and 21 days, was more evident and in larger quantity for the Sr4 group, when compared to the other groups, although some positive nodules were also seen for Sr3 ( Figure 9 ).
| D ISCUSS I ON
One of the most important processes considering periodontal regeneration is inducing the proliferation and differentiation of the PDLCs into cells leading to de novo formation of the lost tissues. 7 In the past decades, there have been many attempts in dental pharmacology F I G U R E 3 ALP activity of the PDLCs (mean ± SD) for the control and the diverse Sr concentrations at the two evaluation periods. The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. aaa-difference from Ctrl, P ≤ 0.001; bbb-difference from Sr1, P ≤ 0.001; ccc-difference from Sr2, P ≤ 0.001; ddd-difference from Sr3, P ≤ 0.001; Tukey post hoc test followed ANOVA F I G U R E 4 RUNX2 gene expression of the PDLCs (mean ± SD), assessed by RT-PCR. The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. a-difference from Ctrl, P ≤ 0.05; aa-difference from Ctrl, P ≤ 0.01; aaa-difference from Ctrl, P ≤ 0.001; b-difference from Sr1, P ≤ 0.05; bbb-difference from Sr1, P ≤ 0.001; cdifference from Sr2, P ≤ 0.05; cc-difference from Sr2, P ≤ 0.01; ccc-difference from Sr2, P ≤ 0.001; ddd-difference from Sr3, P ≤ 0.001; Tukey post hoc test followed ANOVA F I G U R E 5 ALP gene expression of the PDLCs (mean ± SD), assessed by RT-PCR. The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. a-difference from Ctrl, P ≤ 0.05; aa-difference from Ctrl, P ≤ 0.01; aaa-difference from Ctrl, P ≤ 0.001; b-difference from Sr1, P ≤ 0.05; bb-difference from Sr1, P ≤ 0.01; bbbdifference from Sr1, P ≤ 0.001; ccc-difference from Sr2, P ≤ 0.001; ddd-difference from Sr3, P ≤ 0.001; Tukey post hoc test followed ANOVA F I G U R E 6 OPN gene expression of the PDLCs (mean ± SD), assessed by RT-PCR. The letters on top of each bar indicate statistical difference among the groups within the same period of evaluation. a-difference from Ctrl, P ≤ 0.05; aaa-difference from Ctrl, P ≤ 0.001; b-difference from Sr1, P ≤ 0.05; bbbdifference from Sr1, P ≤ 0.001; c-difference from Sr2, P ≤ 0.05; ccc-difference from Sr2, P ≤ 0.001; ddd-difference from Sr3, P ≤ 0.001; Tukey post hoc test followed ANOVA and guided tissue regeneration to improve the condition for the remaining PDLCs in a compromised tooth in order for these cells to perform their function in the regeneration of PDL. 16 Among the tissues which could be regenerated, bone is one of the most studied.
As a result, the differentiation of PDLCs into osteoblast-like cells is a highly relevant feature in tissue engineering. 9 In the present study, the choice of PDLCs was related to the osteoblast-like characteristics of this specific cell population. 16 The literature suggests that roughly 30% of PDLCs retain the potential to differentiate into cells with osteoblastic properties. 7 To stimulate and enhance this differentiation process, several substances have been tested, ranging from bonelike materials (eg, hydroxyapatite), 19 to vitamins, 20 polypeptides, and proteins (eg, enamel matrix derivatives 21 and bone morphogenetic proteins -BMPs). 22 A recently added candidate to be included in this test-list is Sr. 10, 11 This addition is mostly related to the so-called dual action of Sr: it can promote new bone formation by inducing the differentiation of pre-osteoblastic cells into osteoblasts 23 and inhibit the formation and activation of bone resorbing cells (ie, osteoclasts). 24 Additionally, studies also refer to a possible antibacterial activity of Sr, which could be beneficial in the event of using this substance as an enhancer for regenerative procedures. 25, 26 In the present study, the higher Sr concentration tested (Sr4) enhanced PDLCs growth and osteogenic behavior (ie, gene expression and mineralization), considering all used assessment methodologies.
This high concentration of Sr was selected to be comparable to that reported as possible in an actual in vivo system regarding local delivery of Sr. 10 A few other substances have been found to achieve similar results, mostly platelet-derived growth factor (PDGF), platelet-rich plasma (PRP), and BMPs. [27] [28] [29] On the other hand, such substances have also been associated with some disadvantages such as high costs, high supra-physiological doses of growth factors, as well as unwanted side effects associated with recombinant therapies. 30 Studies reporting on possible side effects of Sr administration (local and systemic) have no findings which would support such deleterious effects. 10, 31, 32 In such studies, the tested Sr concentration was either based on what is relevant for the treatment of osteoporosis and bone pathologies (in the dose of 2 mg of strontium ranelate per day), 31, 32 or being locally delivered from implant surfaces, as an attempt to enhance the osseointegration of the implants. 10 This goes toward the results of the only study found in the literature regarding the use of Sr for enhancing the proliferation of PDLCs, which also ratifies the promotion of PDLC proliferation following the use of high concentration of Sr. 16 In the referred study, it is found that Sr in the concentration of 3 mmol/L (or approximately 260 mg/L) also lead to a significant increase in the cell count of a PDLC population. 16 This concentration is intermediate to Sr3 and Sr4 as tested in the present study, and therefore ratifies the present findings.
Regarding the mechanisms that could be related to this effect on PDLC proliferation, there are several options described in the literature, which could be used to support the present findings. One of these mechanisms would be the interaction with the mitogenactivated protein kinase (MAPK) signaling pathway, which enhances the differentiation of mesenchymal stem cells into osteogenic cells. 33 Further, Sr is known to induce prostaglandin production and cyclooxygenase expression in undifferentiated cells, thereby increasing their osteoblastic differentiation. 34 Also, Sr might interact with fibroblast growth factor receptors present in the PDLCs, thereby promoting osteoblast synthetic activity. 35 Another plausible mechanism would be the interaction with the cellular calcium-sensing receptor (or another functionally different cation-sensing receptor) leading to its activation in the osteoblastic cells, which would interfere in all phases of bone production, starting with cell differentiation and proliferation, therefore leading to enhanced bone matrix production.
36
With the intent to gain more knowledge regarding these cellular mechanisms, in the present study we also evaluated the osteogenic behavior of PDLCs, by assessing ALP activity, and the expression planation for the present findings is that although RUNX2 triggers the expression of major bone matrix protein genes, it does not play a major role in the maintenance of the osteogenic gene expression profile in mature osteoblasts. 37 During bone tissue formation, RUNX2 induces osteoblast differentiation and increases the number of cells forming immature bone, whereas RUNX2 expression has to be down-regulated for differentiation into mature osteoblasts, which form mature bone. 37 In other words, RUNX2 triggers the expression of major bone matrix genes during the early stages of osteoblast differentiation, but it is not essential for the maintenance of gene expression in mature osteoblast. [38] [39] [40] Supporting the present results (ie, low RUNX2 gene expression levels), studies focusing on the regulation of cell cycle progression suggest that RUNX2 expression increases when cell proliferation is slow, but it is markedly reduced during rapid cell proliferation. 41, 42 As for ALP, other studies with PDLCs point to the fact that, when cell proliferation is increased (as seen for Sr4), ALP gene expression will be down-regulated. 43, 44 This is also in agreement with the significant up-regulation of OCN and OPN observed from 7 days. In relation to this, multiple mechanisms supporting the present results have been identified.
The most prominent of these is the one suggesting that Sr would act in a somewhat similar fashion as BMP-2, through the activation of the Wnt/β-catenin pathway. 45 In that direction, and similar to what is seen for BMP-2, Sr would interfere with the activation of the Wnt/β-catenin pathway, causing the translocation of transcription factor nuclear factor of activated T cells (NFAT) to the cell nucleus. 45 This would up-regulate β-catenin activation, affecting cell replication processes. Our findings regarding OCN and OPN expression also support the hypothesis regarding the interference of Sr in the Wnt/β-catenin pathway. This is the case since both proteins are directly linked to the same early osteoblastic differentiation phases connected to ALP and RUNX2, as stated above. 46 Further investigation is needed defining the mechanism(s) of action of the high Sr concentrations on the osteogenic behavior of PDLCs.
Concerning the potential action of Sr suppressing bone resorption, significant changes regarding OPG expression were also found to be associated with the highest Sr concentration (Sr4) at 7 days). 51 The final outcome which could be altered within the bone formation pathway, ie, the deposition of mineralized bone matrix, was also assessed by examining the effect of the tested Sr concentrations on the deposition of Ca-rich minerals. The observed increase in OCN expression also suggests that mineralization was ongoing, since F I G U R E 9 Representative images of the Alizarin Red staining for Ca deposits (bone nodules) for the diverse Sr concentrations at the two evaluation periods. Magnification rate, 10x. A control group containing Sr4, but with no cells, was also tested (Ctrl/Sr4), to allow the visualization of false-positive results due to possible interaction between Sr in high concentrations and the Alizarin Red staining. The scale bars in the lower left corner of each image represent 100 μm OCN is secreted by osteoblastic cells and directly implicated in the bone mineralization process. 46 The present results show that mineralization was more pronounced for the Sr4 group, when compared to Sr1-3 and Ctrl groups. This finding is in line with the available literature, in which numerous reports of the concentration-dependent effect of Sr in the mineralization of bone tissue are found. 45, 52, 53 In the present study, such phenomenon could not be observed, since the tested Sr concentrations were not selected based on a gradual, linear increase. Further, mineralization was apparently altered in a significant manner only for the highest tested Sr concentration.
Finally, and supporting the present findings, one should notice that the culture medium used in the present study was a regular culture medium, and not an osteogenic medium (eg, Dulbecco's modified
Eagle's medium -DMEM). This selection was done to avoid possible biases that would eventually lead to the differentiation of the PDLCs into osteoblasts enhanced by other issues rather than the presence of Sr in the medium. In the end, the only variable of this study was the diverse Sr concentrations, as initially suggested in the objectives.
In conclusion, PDLCs responded to a high concentration of Sr 
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